Net Cash Provided by (Used in) Financing Activities of MEDIFAST INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
MEDIFAST INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • MEDIFAST INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $563,000, a 62% increase year-over-year.
  • MEDIFAST INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $564,000, a 63% increase from 2024.
  • MEDIFAST INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,515,000, a 98% increase from 2023.
  • MEDIFAST INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $79,789,000, a 60% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

MEDIFAST INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $564,000 +$951,000 +63% 01 Jan 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
2024 $1,515,000 +$78,274,000 +98% 01 Jan 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
2023 $79,789,000 +$119,792,000 +60% 01 Jan 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
2022 $199,581,000 -$74,448,000 -59% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $125,133,000 -$67,989,000 -119% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $57,144,000 +$25,180,000 +31% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $82,324,000 -$28,996,000 -54% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $53,328,000 -$35,966,000 -207% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $17,362,000 -$4,441,000 -34% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $12,921,000 -$1,190,000 -10% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $11,731,000 +$23,210,000 +66% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
2014 $34,941,000 -$11,628,000 -50% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016 2015 FY
2013 $23,313,000 -$20,388,000 -697% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $2,925,000 +$17,974,000 +86% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
2011 $20,899,000 -$22,232,000 -1668% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014 2013 FY
2010 $1,333,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY

MEDIFAST INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $563,000 +$928,000 +62% 01 Jan 2025 31 Mar 2025 10-Q 28 Apr 2025 2025 Q1
Q1 2024 $1,491,000 +$24,405,000 +94% 01 Jan 2024 31 Mar 2024 10-Q 28 Apr 2025 2025 Q1
Q1 2023 $25,896,000 +$2,223,000 +7.9% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024 2024 Q1
Q1 2022 $28,119,000 -$5,901,000 -27% 01 Jan 2022 31 Mar 2022 10-Q 01 May 2023 2023 Q1
Q1 2021 $22,218,000 -$8,477,000 -62% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022 2022 Q1
Q1 2020 $13,741,000 -$4,928,000 -56% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $8,813,000 -$2,777,000 -46% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $6,036,000 -$1,901,000 -46% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $4,135,000 -$533,000 -15% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2016 $3,602,000 -$2,880,000 -399% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q1 2015 $722,000 -$674,000 -1404% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $48,000 +$3,367,000 +99% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $3,415,000 -$3,149,000 -1184% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $266,000 -$524,000 -203% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $258,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.